Alle Fälle anzeigen
UPC APP 11272/2025
—·EP2401365: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieSonstige prozessuale
- Parteien
- Beklagte
- BioNTech SE
- BioNTech Manufacturing GmbH
- BioNTech Manufacturing Marburg GmbH
- BioNTech Innovative Manufacturing Services GmbH
- BioNTech Europe GmbH
- Pfizer Manufacturing Belgium NV
- Pfizer SAS
- Pfizer AB
- Pfizer, Inc.
Vertreter: Christine Kanz (Hoyng Rokh Monegier) - Division
- Munich LD
- Richter
- Andras Kupecz · Judge-Rapporteur (Munich Local Division, Panel 2)
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 9. Apr. 2025
Entscheidungen
- 2025-04-09Generic application
The Munich Local Division issued an order on Promosome LLC v. BioNTech/Pfizer infringement proceedings (EP 2 401 365), addressing security for costs applications by both BioNTech/Pfizer groups. The court determined the appropriate amount of security, accepting the claimant's willingness to provide security by deposit. The court fixed the security amount based on the recoverable costs ceiling rather than the defendants' requested EUR 5,000,000.
Rechtsfragen:Security for costs (R. 158 RoP, Art. 69.4 UPCA)Amount of security: German RVG vs. UPC cost ceilingSecurity by deposit vs. bank guarantee
Dokumente
- 6C7EEEDF5801EB90DEB559E1EFC67FE0_en.pdf2025-04-09EN